GAZZERRO, PATRIZIA
GAZZERRO, PATRIZIA
Update on the endocannabinoid system as an anticancer target
2011 Malfitano, A. M.; Ciaglia, E.; Gangemi, G.; Gazzerro, P.; Laezza, C.; Bifulco, M.
Pharmacological actions of statins: A critical appraisal in the management of cancer
2012 Gazzerro, P.; Proto, M. C.; Gangemi, G.; Malfitano, A. M.; Ciaglia, E.; Pisanti, S.; Santoro, A.; Laezza, C.; Bifulco, M.
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation
2013 Ciaglia, E.; Pisanti, S.; Picardi, P.; Laezza, C.; Malfitano, A. M.; D'Alessandro, A.; Gazzerro, P.; Vitale, M.; Carbone, E.; Bifulco, M.
Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets
2021 Proto, M. C.; Fiore, D.; Piscopo, C.; Pagano, C.; Galgani, M.; Bruzzaniti, S.; Laezza, C.; Gazzerro, P.; Bifulco, M.
NMR for screening and a biochemical assay: Identification of new FPPS inhibitors exerting anticancer activity
2020 Grimaldi, M.; Randino, R.; Ciaglia, E.; Scrima, M.; Buonocore, M.; Stillitano, I.; Abate, M.; Covelli, V.; Tosco, A.; Gazzerro, P.; Bifulco, M.; Rodriquez, M.; D'Ursi, A. M.
Statins in coronavirus outbreak: It's time for experimental and clinical studies
2020 Bifulco, M.; Gazzerro, P.
Statin therapy in COVID-19 infection: Much more than a single pathway
2020 Bifulco, M.; Gazzerro, P.
The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed
2021 Bifulco, M.; Ciccarelli, M.; Bruzzese, D.; Dipasquale, A.; Lania, A. G.; Mazziotti, G.; Gazzerro, P.
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives
2013 Malfitano, Am; Laezza, C; Saccomanni, G; Tuccinardi, T; Manera, C; Martinelli, A; Ciaglia, E; Pisanti, S; Vitale, M; Gazzerro, P; Bifulco, M
Statins and cancer-related mortality: an open question
2013 Gazzerro, Patrizia; Ciaglia, Elena; Bifulco, Maurizio
Statins and cancer in gastroenterology: new insight?
2013 Gazzerro, Patrizia; Bifulco, Maurizio
Cannabinoids and cancer: pros and cons of an antitumour strategy
2006 Bifulco, Maurizio; Laezza, C; Pisanti, S; Gazzerro, Patrizia
Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. (review)
2007 Bifulco, Maurizio; Grimaldi, C; Gazzerro, Patrizia; Pisanti, S; Santoro, Antonietta
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells
2007 Malfitano, Am; Toruner, Ga; Gazzerro, Patrizia; Laezza, C; Husain, S; Eletto, D; Orlando, P; DE PETROCELLIS, L; Terskiy, A; Schwalb, M; Vitale, E; Bifulco, Maurizio
Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy
2007 Pisanti, S; Borselli, C; Oliviero, O; Laezza, C; Gazzerro, Patrizia; Bifulco, Maurizio
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review)
2007 Bifulco, M.; Laezza, C; Gazzerro, P; Pentimalli, F
Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. Int J Obesity
2007 Gazzerro, Patrizia; Mg, Caruso; M., Notarnicola; G., Misciagna; V., Guerra; C., Laezza; Bifulco, Maurizio
Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer"
2008 Santoro, Antonietta; Gazzerro, Patrizia; Malfitano, Am; Pisanti, S; Laezza, C; Bifulco, Maurizio
Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: involvement of PARP-1 and p53 proteins
2008 Santoro, A; Bianco, G; Picerno, P; Aquino, Rp; Autore, G; Marzocco, S; Gazzerro, P; Lioi, Mb; Bifulco, M.
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells
2008 Malfitano, Am; Laezza, C; Pisanti, S; Gazzerro, Patrizia; Bifulco, Maurizio
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Update on the endocannabinoid system as an anticancer target | 1.1 Articolo in rivista | 2011 | Malfitano, A. M.; Ciaglia, E.; Gangemi, G.; Gazzerro, P.; Laezza, C.; Bifulco, M. | |
| Pharmacological actions of statins: A critical appraisal in the management of cancer | 1.1 Articolo in rivista | 2012 | Gazzerro, P.; Proto, M. C.; Gangemi, G.; Malfitano, A. M.; Ciaglia, E.; Pisanti, S.; Santoro, A.; Laezza, C.; Bifulco, M. | |
| N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation | 1.1 Articolo in rivista | 2013 | Ciaglia, E.; Pisanti, S.; Picardi, P.; Laezza, C.; Malfitano, A. M.; D'Alessandro, A.; Gazzerro, P.; Vitale, M.; Carbone, E.; Bifulco, M. | |
| Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets | 1.1 Articolo in rivista | 2021 | Proto, M. C.; Fiore, D.; Piscopo, C.; Pagano, C.; Galgani, M.; Bruzzaniti, S.; Laezza, C.; Gazzerro, P.; Bifulco, M. | |
| NMR for screening and a biochemical assay: Identification of new FPPS inhibitors exerting anticancer activity | 1.1 Articolo in rivista | 2020 | Grimaldi, M.; Randino, R.; Ciaglia, E.; Scrima, M.; Buonocore, M.; Stillitano, I.; Abate, M.; Covelli, V.; Tosco, A.; Gazzerro, P.; Bifulco, M.; Rodriquez, M.; D'Ursi, A. M. | |
| Statins in coronavirus outbreak: It's time for experimental and clinical studies | 1.1 Articolo in rivista | 2020 | Bifulco, M.; Gazzerro, P. | |
| Statin therapy in COVID-19 infection: Much more than a single pathway | 1.1 Articolo in rivista | 2020 | Bifulco, M.; Gazzerro, P. | |
| The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed | 1.1 Articolo in rivista | 2021 | Bifulco, M.; Ciccarelli, M.; Bruzzese, D.; Dipasquale, A.; Lania, A. G.; Mazziotti, G.; Gazzerro, P. | |
| Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives | 1.1 Articolo in rivista | 2013 | Malfitano, Am; Laezza, C; Saccomanni, G; Tuccinardi, T; Manera, C; Martinelli, A; Ciaglia, E; Pisanti, S; Vitale, M; Gazzerro, P; Bifulco, M | |
| Statins and cancer-related mortality: an open question | 1.1 Articolo in rivista | 2013 | Gazzerro, Patrizia; Ciaglia, Elena; Bifulco, Maurizio | |
| Statins and cancer in gastroenterology: new insight? | 1.1 Articolo in rivista | 2013 | Gazzerro, Patrizia; Bifulco, Maurizio | |
| Cannabinoids and cancer: pros and cons of an antitumour strategy | 1.1 Articolo in rivista | 2006 | Bifulco, Maurizio; Laezza, C; Pisanti, S; Gazzerro, Patrizia | |
| Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. (review) | 1.1 Articolo in rivista | 2007 | Bifulco, Maurizio; Grimaldi, C; Gazzerro, Patrizia; Pisanti, S; Santoro, Antonietta | |
| Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells | 1.1 Articolo in rivista | 2007 | Malfitano, Am; Toruner, Ga; Gazzerro, Patrizia; Laezza, C; Husain, S; Eletto, D; Orlando, P; DE PETROCELLIS, L; Terskiy, A; Schwalb, M; Vitale, E; Bifulco, Maurizio | |
| Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy | 1.1 Articolo in rivista | 2007 | Pisanti, S; Borselli, C; Oliviero, O; Laezza, C; Gazzerro, Patrizia; Bifulco, Maurizio | |
| Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review) | 1.1 Articolo in rivista | 2007 | Bifulco, M.; Laezza, C; Gazzerro, P; Pentimalli, F | |
| Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. Int J Obesity | 1.1 Articolo in rivista | 2007 | Gazzerro, Patrizia; Mg, Caruso; M., Notarnicola; G., Misciagna; V., Guerra; C., Laezza; Bifulco, Maurizio | |
| Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer" | 1.7 Commento, erratum, replica e simili | 2008 | Santoro, Antonietta; Gazzerro, Patrizia; Malfitano, Am; Pisanti, S; Laezza, C; Bifulco, Maurizio | |
| Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: involvement of PARP-1 and p53 proteins | 1.1 Articolo in rivista | 2008 | Santoro, A; Bianco, G; Picerno, P; Aquino, Rp; Autore, G; Marzocco, S; Gazzerro, P; Lioi, Mb; Bifulco, M. | |
| Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells | 1.1 Articolo in rivista | 2008 | Malfitano, Am; Laezza, C; Pisanti, S; Gazzerro, Patrizia; Bifulco, Maurizio |